# Innoviva, Inc.: Form 10-K/A for the period ended Dec 31, 2021

- Company: [Innoviva, Inc.](/companies/inva.md) (CIK 1080014)
- Form: 10-K/A
- Filed: 2022-03-17
- Accepted by EDGAR: Mar 17, 2022, 16:12 ET
- Period: 2021-12-31
- Accession: 0000950170-22-004088
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1080014/000095017022004088/inva-20211231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1080014/000095017022004088/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2021-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2021-01-01 to 2021-12-31 | $391.9m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Research and development | 12 months, 2021-01-01 to 2021-12-31 | $576.0k | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months, 2021-01-01 to 2021-12-31 | $375.1m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2021-01-01 to 2021-12-31 | $19.1m | us-gaap:InterestExpense |
| Income tax | 12 months, 2021-01-01 to 2021-12-31 | $76.4m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2021-01-01 to 2021-12-31 | $368.8m | us-gaap:ProfitLoss |
| Diluted EPS | 12 months, 2021-01-01 to 2021-12-31 | $2.87 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2021-01-01 to 2021-12-31 | $3.24 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2021-01-01 to 2021-12-31 | 94,310,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2021-01-01 to 2021-12-31 | $363.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2021-01-01 to 2021-12-31 | $0 | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months, 2021-01-01 to 2021-12-31 | $0 | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months, 2021-01-01 to 2021-12-31 | $394.1m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2021-12-31 | $201.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2021-12-31 | $313.7m | us-gaap:AssetsCurrent |
| Total assets | at 2021-12-31 | $926.4m | us-gaap:Assets |
| Current liabilities | at 2021-12-31 | $5.8m | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2021-12-31 | $394.7m | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | at 2021-12-31 | $414.7m | us-gaap:StockholdersEquity |

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1080014/000095017022004088/inva-20211231.htm

Filed Mar 17, 2022.
Source: SEC EDGAR, the filing index for accession 0000950170-22-004088. Last ingested by Listed: Nov 4, 2026, 17:42 ET. No prices; not investment advice.